These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9035142)

  • 1. Design and production of novel tetravalent bispecific antibodies.
    Coloma MJ; Morrison SL
    Nat Biotechnol; 1997 Feb; 15(2):159-63. PubMed ID: 9035142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
    Biburger M; Weth R; Wels WS
    J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies.
    Davis JH; Aperlo C; Li Y; Kurosawa E; Lan Y; Lo KM; Huston JS
    Protein Eng Des Sel; 2010 Apr; 23(4):195-202. PubMed ID: 20299542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
    Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
    Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
    Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
    Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies.
    Golay J; Choblet S; Iwaszkiewicz J; Cérutti P; Ozil A; Loisel S; Pugnière M; Ubiali G; Zoete V; Michielin O; Berthou C; Kadouche J; Mach JP; Duonor-Cérutti M
    J Immunol; 2016 Apr; 196(7):3199-211. PubMed ID: 26921308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
    Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
    Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first constant domain (C(H)1 and C(L)) of an antibody used as heterodimerization domain for bispecific miniantibodies.
    Müller KM; Arndt KM; Strittmatter W; Plückthun A
    FEBS Lett; 1998 Jan; 422(2):259-64. PubMed ID: 9490020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of multiform scFv antibodies using linker peptide.
    Wang S; Zheng C; Liu Y; Zheng H; Wang Z
    J Genet Genomics; 2008 May; 35(5):313-6. PubMed ID: 18499076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody.
    Lu D; Jimenez X; Witte L; Zhu Z
    Biochem Biophys Res Commun; 2004 May; 318(2):507-13. PubMed ID: 15120630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric human-mouse IgG antibodies with shuffled constant region exons demonstrate that multiple domains contribute to in vivo half-life.
    Zuckier LS; Chang CJ; Scharff MD; Morrison SL
    Cancer Res; 1998 Sep; 58(17):3905-8. PubMed ID: 9731501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant approaches to IgG-like bispecific antibodies.
    Marvin JS; Zhu Z
    Acta Pharmacol Sin; 2005 Jun; 26(6):649-58. PubMed ID: 15916729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).
    Heng BC; Cao T
    Med Hypotheses; 2005; 64(6):1105-8. PubMed ID: 15823695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The assembly of single domain antibodies into bispecific decavalent molecules.
    Stone E; Hirama T; Tanha J; Tong-Sevinc H; Li S; MacKenzie CR; Zhang J
    J Immunol Methods; 2007 Jan; 318(1-2):88-94. PubMed ID: 17141798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and production of an IgG-like tetravalent bispecific antibody for enhanced therapeutic efficacy.
    Lu D; Zhu Z
    Methods Mol Biol; 2009; 525():377-404, xiv. PubMed ID: 19252849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded bispecific antibody comprising of two single-chain antibodies linked to the antibody constant region.
    Natsume A; Wakitani M; Yamane-Ohnuki N; Shoji-Hosaka E; Niwa R; Uchida K; Satoh M; Shitara K
    J Biochem; 2006 Sep; 140(3):359-68. PubMed ID: 16861252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y; Li X; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction, purification, and characterization of anti-BAFF scFv-Fc fusion antibody expressed in CHO/dhfr- cells.
    Cao M; Cao P; Yan H; Lu W; Ren F; Hu Y; Zhang S
    Appl Biochem Biotechnol; 2009 Jun; 157(3):562-74. PubMed ID: 19099209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivalent monoclonal IgY antibody formats by conversion of recombinant antibody fragments.
    Greunke K; Spillner E; Braren I; Seismann H; Kainz S; Hahn U; Grunwald T; Bredehorst R
    J Biotechnol; 2006 Jul; 124(2):446-56. PubMed ID: 16490273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.